blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1824414

EP1824414 - COMPOSITIONS, SYSTEMS AND METHODS FOR TREATMENT OF DEFECTS IN BLOOD VESSELS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.02.2020
Database last updated on 21.01.2025
FormerGrant of patent is intended
Status updated on  16.05.2019
FormerExamination is in progress
Status updated on  01.12.2017
Most recent event   Tooltip21.02.2020Application deemed to be withdrawnpublished on 25.03.2020  [2020/13]
Applicant(s)For all designated states
MicroVention, Inc.
75 Columbia, Suite A
Aliso Viejo, CA 92656 / US
[2007/42]
Former [2007/35]For all designated states
Microvention, Inc.
75 Columbia, Suite A
Aliso Viejo, CA 92656 / US
Inventor(s)01 / CRUISE, Gregory, M.
74 San Bonifacio
Rancho Santa Margarita, CA 92688 / US
 [2007/35]
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[N/P]
Former [2013/37]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham
NG1 5GG / GB
Former [2007/35]Baker, Colin John
Eric Potter Clarkson LLP Park View House 58 The Ropewalk
Nottingham NG1 5DD / GB
Application number, filing date05823232.316.11.2005
[2007/35]
WO2005US41637
Priority number, dateUS2004099094216.11.2004         Original published format: US 990942
[2007/35]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006055690
Date:26.05.2006
Language:EN
[2006/21]
Type: A2 Application without search report 
No.:EP1824414
Date:29.08.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 26.05.2006 takes the place of the publication of the European patent application.
[2007/35]
Search report(s)International search report - published on:US22.02.2007
(Supplementary) European search report - dispatched on:EP30.05.2012
ClassificationIPC:A61F2/04, A61F2/06, A61L24/00, A61L24/04, A61L31/16, A61L31/18
[2012/26]
CPC:
A61B17/12022 (EP,US); A61B17/12113 (EP,US); A61B17/12136 (EP,US);
A61B17/12181 (EP,US); A61B17/12186 (EP,US); A61L24/0015 (EP,US);
A61L24/043 (EP,US); A61L31/16 (EP,US); A61L31/18 (EP,US);
A61P9/00 (EP); A61P9/14 (EP); A61B2017/1205 (EP,US);
A61B2017/22051 (EP,US); A61B2017/22067 (EP,US); A61L2300/414 (EP,US);
A61L2300/64 (EP,US) (-)
Former IPC [2007/35]A61F2/04, A61F2/06
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/35]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:ZUSAMMENSETZUNGEN, SYSTEME UND VERFAHREN ZUR BEHANDLUNG VON BLUTGEFÄSSDEFEKTEN[2007/35]
English:COMPOSITIONS, SYSTEMS AND METHODS FOR TREATMENT OF DEFECTS IN BLOOD VESSELS[2007/35]
French:COMPOSITIONS, SYSTEMES ET PROCEDES POUR LE TRAITEMENT D'ANOMALIES DANS DES VAISSEAUX SANGUINS[2007/35]
Entry into regional phase15.06.2007National basic fee paid 
15.06.2007Search fee paid 
15.06.2007Designation fee(s) paid 
15.06.2007Examination fee paid 
Examination procedure15.06.2007Examination requested  [2007/35]
14.12.2007Amendment by applicant (claims and/or description)
05.12.2017Despatch of a communication from the examining division (Time limit: M04)
28.03.2018Reply to a communication from the examining division
17.05.2019Communication of intention to grant the patent
28.09.2019Application deemed to be withdrawn, date of legal effect  [2020/13]
08.11.2019Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2020/13]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.12.2017
Fees paidRenewal fee
27.11.2007Renewal fee patent year 03
25.11.2008Renewal fee patent year 04
25.11.2009Renewal fee patent year 05
24.11.2010Renewal fee patent year 06
23.11.2011Renewal fee patent year 07
13.11.2012Renewal fee patent year 08
18.11.2013Renewal fee patent year 09
10.11.2014Renewal fee patent year 10
10.11.2015Renewal fee patent year 11
10.11.2016Renewal fee patent year 12
13.11.2017Renewal fee patent year 13
14.11.2018Renewal fee patent year 14
Penalty fee
Additional fee for renewal fee
30.11.201915   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP0664104  (MICRO THERAPEUTICS INC [US]) [X] 1-9,33-35 * column 11, line 42 - column 12, line 28; figure - *;
 [X]WO9722371  (COLLAGEN CORP [US]) [X] 1-35 * page 15, line 20 - page 16, line 19 * * page 17, line 31 - page 18, line 2 * * page 32, line 15 - page 33, line 14 *;
 [X]WO9955239  (MICROVENTION INC [US]) [X] 1-9,22,23,33-35 * page 5, line 23 - line 26 * * page 11, line 1 - line 5 * * page 16, line 14 - line 28 *;
 [A]WO0168720  (BIOCURE INC [US], et al) [A] 1-35* claim - *;
 [A]US2001051670  (GOUPIL DENNIS W [US], et al) [A] 1-35 * claim - *;
 [A]US2002082636  (SAWHNEY AMARPREET S [US], et al) [A] 1-35 * figure -; claim - *;
 [A]WO03020357  (MICRO THERAPEUTICS INC [US], et al) [A] 1-35 * claim - *;
 [X]US6703047  (SAWHNEY AMARPREET S [US], et al) [X] 1,10-19,33-35 * column 4, line 1 - line 67 * * column 7, line 5 - line 34 *
International search[A]US6562362  (BAE YOU HAN [KR], et al);
 [A]US6808518  (WELLMAN PARRIS S [US], et al);
 [AT]US2005245893  (LESCHINSKY BORIS [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.